Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Ketone Monitors for Safe Use of Sotagliflozin in Type 1 Diabetes
NCT07211802Phase 3Not yet recruiting
- Sponsor
- University of California, San Diego
- Start
- Apr 2027
- Primary completion
- Jul 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sotagliflozin in type 1 diabetes mellitus (T1D), sponsored by University of California, San Diego. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07211802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211802.